Entera Bio Ltd. (ENTX)
Entera Bio Ltd. is a biopharmaceutical firm in the clinical development phase, dedicated to creating and marketing oral medications composed of large molecules, addressing medical conditions that currently lack adequate treatments. Its primary experimental drugs are EB612, currently undergoing Phase II clinical assessment for hypoparathyroidism, and EB613, which has concluded Phase II studies for osteoporosis and is now in Phase I trials for treating non-healing bone fractures. Furthermore, the company holds a collaborative research and licensing pact with Amgen Inc. aimed at identifying and advancing potential therapeutic compounds for inflammatory conditions and other grave ailments. Established in 2009, Entera Bio Ltd. operates from its headquarters in Jerusalem, Israel.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Entera Bio Ltd.
NASDAQ:ENTXHealthcare · Biotechnology
+2.56%$3.20
AH$3.22+0.61%vs close
Mkt Cap$556.55M
Float159.35M
O/S173.92M
Vol
$ Vol
RVOL
Inst Own2.8%
SI3.5%
Earnings
Dilution
Financials Summary
Revenue$42K
Net Income-$11.44M
Total Assets$15.99M
Free Cash Flow-$7.48M
Debt & Equity
Debt 4%
Equity 96%
Total Debt$490K
Total Equity$13.1M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ENTX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$15.99M
Liabilities$2.89M
Accounts Receivable$219K
Accounts Payable$448K
Inventory$0
PP&E (Net)$134K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Revenue | $42K | $181K | $0 | $134K | $571K | $365K | $236K | $500K | $0 | $0 | $0 |
| YoY Growth | -76.8% | - | - | -76.5% | 56.4% | 54.7% | -52.8% | - | - | - | - |
| Cost of Revenue | $42K | $172K | $56K | $165K | $373K | $300K | $448K | $0 | $43K | $35K | $28K |
| Gross Profit | $0 | $9K | -$56K | -$31K | $198K | $65K | -$212K | $500K | -$43K | -$35K | -$28K |
| Gross Margin | - | 5.0% | - | -23.1% | 34.7% | 17.8% | -89.8% | 100.0% | - | - | - |
| Research and Development | $6M | $4.5M | $4.45M | $5.78M | $6.77M | $6.38M | $6.96M | $8.52M | $2.77M | $2.65M | $2.12M |
| Selling, General, and Administrative | $5.53M | $5.09M | $4.43M | $7.25M | $5.69M | $4.85M | $4.28M | $2.84M | $8.57M | $2.72M | $1.59M |
| Other | $0 | $0 | $0 | $0 | -$46K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $11.53M | $9.59M | $8.88M | $13.04M | $12.41M | $11.23M | $11.24M | $11.36M | $11.34M | $5.37M | $3.7M |
| Operating Income (EBIT) | -$11.53M | -$9.59M | -$8.94M | -$13.07M | -$12.22M | -$11.17M | -$11.45M | -$10.86M | $11.34M | -$5.37M | -$3.7M |
| Operating Margin | -27450.0% | -5295.6% | - | -9752.2% | -2139.6% | -3059.7% | -4853.4% | -2172.2% | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $29K | $28K | $84K | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $58K | $31K | $83K | $0 | $0 | $0 | $34K | $0 | $0 | $0 |
| Other Income (Expense) | $90K | $58K | $80K | $134K | -$29K | -$28K | $659K | $557K | $146K | $4.17M | -$581K |
| Income Before Tax (EBT) | -$11.44M | -$9.53M | -$8.86M | -$12.93M | -$12.25M | -$11.2M | -$10.79M | -$10.3M | -$11.2M | -$1.2M | -$4.28M |
| Income Tax Expense | $0 | $14K | $29K | $137K | -$59K | $20K | $0 | $0 | -$146K | $0 | $0 |
| Net Income | -$11.44M | -$9.54M | -$8.89M | -$13.07M | -$12.19M | -$11.22M | -$10.79M | -$10.3M | -$11.2M | -$1.2M | -$4.28M |
| Net Income Margin | -27235.7% | -5271.3% | - | -9754.5% | -2134.3% | -3072.9% | -4574.2% | -2060.8% | - | - | - |
| Supplementary Data | |||||||||||
| EPS | -0.25 | -0.25 | -0.31 | -0.45 | -0.47 | -0.54 | -0.90 | -0.91 | -1.31 | -0.14 | -0.36 |
| Diluted EPS | -0.25 | -0.25 | -0.31 | -0.45 | -0.47 | -0.54 | -0.90 | -1.29 | -0.94 | -0.10 | -0.36 |
| Weighted Average OS | 46.19M | 37.65M | 29.01M | 28.81M | 26.13M | 18.42M | 12.15M | 11.37M | 8.57M | 8.57M | 11.90M |
| EBITDA | -$11.41M | -$9.48M | -$8.8M | -$12.87M | -$12.16M | -$11.11M | -$10.47M | -$10.81M | -$11.05M | -$5.33M | -$3.67M |
| EBITDA Margin | -27164.3% | -5238.1% | - | -9604.5% | -2130.3% | -3042.5% | -4437.7% | -2161.4% | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $7.11M | $8.66M | $11.02M | $12.31M | $24.89M | $8.59M | $15.22M | $7.51M | $11.75M | $4.16M | $1.21M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4.01M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $7.11M | $8.66M | $11.02M | $12.31M | $24.89M | $8.59M | $15.22M | $11.52M | $11.75M | $4.16M | $1.21M |
| Accounts Receivable | $219K | $126K | $0 | $246K | $183K | $255K | $278K | $725K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $130K | $0 | $0 | $0 |
| Other Current Assets | -$219K | $186K | $238K | $294K | $254K | $163K | $97K | $111K | $182K | $1.23M | $160K |
| Total Current Assets | $7.11M | $8.97M | $11.26M | $12.85M | $25.33M | $9.11M | $15.64M | $12.47M | $12.42M | $5.43M | $1.9M |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $134K | $332K | $488K | $229K | $395K | $566K | $462K | $224K | $207K | $199K | $193K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $605K | $651K | $654K | $654K | $654K |
| Long-Term Investments | $90K | $80K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $14K | $43K | $217K | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | -$90K | $6K | $6K | $6K | $46K | $47K | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $134K | $418K | $508K | $278K | $658K | $613K | $1.07M | $875K | $861K | $853K | $847K |
| Other Assets | $8.75M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $15.99M | $9.39M | $11.77M | $13.13M | $25.99M | $9.72M | $16.7M | $13.34M | $13.28M | $6.29M | $2.75M |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $448K | $132K | $83K | $17K | $166K | $164K | $334K | $473K | $596K | $53K | $351K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $189K | $177K | $0 | $0 | $9.88M | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $134K | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $15K | $158K | $267K | $225K | $0 | $0 | $0 |
| Other Current Liabilities | $432K | $339K | $500K | $300K | $455K | $923K | $3.24M | $755K | $995K | $294K | $210K |
| Total Current Liabilities | $2.2M | $1.18M | $1.09M | $1.34M | $3.16M | $1.84M | $4.59M | $1.79M | $2.02M | $10.54M | $804K |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $260K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.89M | $15.87M | $21.11M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $429K | $32K | $32K | $32K | $138K | $128K | $70K | $1.44M | $38.92M | $5.12M | $6.51M |
| Total Long-Term Liabilities | $689K | $134K | $288K | $32K | $261K | $371K | $192K | $1.44M | $42.82M | $20.99M | $27.63M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.89M | $1.31M | $1.38M | $1.37M | $3.42M | $2.21M | $4.78M | $3.23M | $44.84M | $31.53M | $28.43M |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $1K | $1K | $1K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$125.37M | -$113.93M | -$104.39M | -$95.5M | -$82.43M | -$70.24M | -$62.91M | -$52.12M | -$41.81M | -$30.62M | -$29.42M |
| Comprehensive Income & Other | $41K | $41K | $41K | $41K | $41K | $8.96M | $11.44M | $13.06M | $7.4M | $2.88M | $1.4M |
| Other Stockholders' Equity | $138.47M | $122.01M | $114.77M | $107.25M | $104.99M | $77.75M | $74.83M | $62.23M | $10.26M | $5.37M | $3.73M |
| Total Equity | $13.1M | $8.08M | $10.39M | $11.75M | $22.57M | $7.51M | $11.92M | $10.12M | -$31.56M | -$25.25M | -$25.69M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $15.99M | $9.39M | $11.77M | $13.13M | $25.99M | $9.72M | $16.7M | $13.34M | $13.28M | $6.29M | $2.75M |
| Supplementary Data | |||||||||||
| Total Debt | $490K | $272K | $390K | $91K | $302K | $432K | $299K | $0 | $3.89M | $14.72M | $8.05M |
| Net Debt | -$6.62M | -$8.39M | -$10.63M | -$12.22M | -$24.59M | -$8.16M | -$14.92M | -$7.51M | -$7.85M | $10.56M | $6.85M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Operating Activities | |||||||||||
| Net Income | -$11.44M | -$9.54M | -$8.89M | -$13.07M | -$12.19M | -$11.22M | -$10.79M | -$10.3M | -$11.2M | -$1.2M | -$4.28M |
| Depreciation & Amortization | $30K | $46K | $56K | $64K | $53K | $63K | $238K | $54K | $43K | $35K | $28K |
| Deferred Income Tax | $0 | $14K | $29K | $174K | -$217K | $0 | $33K | -$41K | -$324K | $22K | $0 |
| Stock-Based Compensation | $2.75M | $2.56M | $1.69M | $2.25M | $1.86M | $901K | $1.48M | $1.23M | $4.88M | $1.49M | $366K |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | $126K | -$126K | $246K | -$63K | $72K | $23K | $447K | -$725K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | -$72K | $0 | $341K | $117K | $0 | $0 | $0 |
| Accounts Payable | $316K | $49K | $66K | -$149K | $74K | -$147K | -$139K | -$123K | $543K | -$298K | $227K |
| Other Working Capital | $815K | $189K | -$507K | -$1.62M | $1.33M | -$227K | $42K | $225K | $366K | $651K | -$410K |
| Total Working Capital Change | $1.26M | $112K | -$195K | -$1.83M | $1.41M | -$351K | $691K | -$506K | $909K | $353K | -$183K |
| Other Non-Cash Items | $32K | -$5K | $0 | -$78K | $18K | $46K | -$569K | -$232K | $1.16M | -$3.84M | $576K |
| Net Cash from Operating | -$7.37M | -$6.82M | -$7.31M | -$12.5M | -$9.06M | -$10.56M | -$8.92M | -$9.8M | -$4.53M | -$3.14M | -$3.5M |
| Investing Activities | |||||||||||
| Capital Expenditures | -$107K | -$3K | -$17K | -$47K | -$17K | -$53K | -$40K | -$68K | -$51K | -$41K | -$54K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$4M | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$55K | $0 | $0 | $3.99M | -$4M | $1.05M | -$1.07M | $0 |
| Net Cash from Investing | -$107K | -$3K | -$17K | -$102K | -$17K | -$53K | $3.95M | -$4.07M | $1M | -$1.12M | -$54K |
| Financing Activities | |||||||||||
| Debt Repaid | - | - | - | - | - | $136K | $114K | - | $980K | -$7.22M | -$2M |
| Common Stock Issuance | $13.71M | $3.96M | $6.62M | $13K | $21.8M | $3.98M | $12.53M | $9.62M | $12.09M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $516K | -$580K | $0 | $3.58M | $204K | $238K | $0 | $0 | $0 | $0 |
| Net Cash from Financing | $13.71M | $4.48M | $6.04M | $13K | $25.38M | $4.05M | $12.65M | $9.62M | $11.11M | $7.22M | $4.46M |
| Forex Effect | -$10K | $0 | $0 | $5K | $0 | $0 | $0 | $0 | $0 | $0 | -$1K |
| Net Change in Cash | $6.23M | -$2.35M | -$1.29M | -$12.58M | $16.3M | -$6.56M | $7.68M | -$4.24M | $7.58M | $2.96M | $915K |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$7.37M | -$6.82M | -$7.31M | -$12.5M | -$9.06M | -$10.56M | -$8.92M | -$9.8M | -$4.53M | -$3.14M | -$3.5M |
| Capital Expenditure | -$107K | -$3K | -$17K | -$47K | -$17K | -$53K | -$40K | -$68K | -$51K | -$41K | -$54K |
| Free Cash Flow | -$7.48M | -$6.82M | -$7.33M | -$12.55M | -$9.08M | -$10.61M | -$8.96M | -$9.86M | -$4.58M | -$3.18M | -$3.55M |
| Cash at Beginning | $8.74M | $11.09M | $12.38M | $24.89M | $8.66M | $15.22M | $7.51M | $11.75M | $4.16M | $1.21M | $290K |
| Cash at End | $14.97M | $8.74M | $11.09M | $12.31M | $24.96M | $8.66M | $15.19M | $7.51M | $11.75M | $4.16M | $1.21M |